Partial angiotensin-converting enzyme inhibition during acute orthostatic stress in persons with tetraplegia

J Spinal Cord Med. 2005;28(2):103-8. doi: 10.1080/10790268.2005.11753806.

Abstract

Introduction: Individuals with tetraplegia rely on the renin-angiotensin system for orthostatic blood pressure control.

Objectives: To determine the effect of partial angiotensin-converting enzyme (ACE) inhibition on heart rate (HR), active plasma renin (PR), and mean arterial blood pressure (MAP) during acute orthostasis in subjects with tetraplegia (n = 7) and nondisabled persons (n = 8).

Methods: Subjects were instructed to avoid caffeine and alcohol for 24 hours before testing and to report to the laboratory between 10 AM and 1 PM. Progressive head-up tilt (15 degrees, 25 degrees, 35 degrees, and 45 degrees) was performed on 2 separate days; Day 1: without ACE inhibition; Day 2: after intravenous (IV) infusion of enalaprilat (0.625 mg).

Results: HR was reduced during orthostasis in the tetraplegia compared with the nondisabled group (P < 0.0001), and was unaffected by ACE inhibition in either group. PR was not increased with orthostasis in either group, but was increased after ACE inhibition in both groups (P < 0.001). MAP was not affected by orthostasis in either group, but was reduced with ACE inhibition in both groups (P < 0.01). In the tetraplegia group, MAP was initially reduced after ACE inhibition, but was maintained thereafter with increasing angles of tilt, and no subject complained of symptomatic orthostatic hypotension.

Conclusion: Subjects with tetraplegia were tolerant of an acute bout of orthostatic stress after partial ACE inhibition. This may have clinical relevance because of the increased prevalence of type 2 diabetes mellitus in this population and the use of ACE inhibitors for the treatment of progressive renal and cardiovascular disease.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Blood Pressure / drug effects*
  • Cervical Vertebrae
  • Dizziness / physiopathology*
  • Enalaprilat / pharmacology*
  • Humans
  • Middle Aged
  • Quadriplegia / etiology
  • Quadriplegia / physiopathology*
  • Renin-Angiotensin System / drug effects*
  • Spinal Cord Injuries / complications
  • Spinal Cord Injuries / physiopathology
  • Tilt-Table Test

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Enalaprilat